First Header Logo Second Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Paul Bunch and Ryan Hughes.
Connection Strength

2.987
  1. Hughes RT, Lack CM, Sachs JR, Hiatt KD, Smith S, Steber CR, Aly FZ, D'Agostino RB, Bunch PM. Predicting Extranodal Extension with Preoperative Contrast-enhanced CT in Patients with Oropharyngeal Squamous Cell Carcinoma. Radiol Imaging Cancer. 2025 Mar; 7(2):e240127.
    View in: PubMed
    Score: 0.917
  2. Bunch PM, Meegalla NT, Abualruz AR, Frizzell BA, Patwa HS, Porosnicu M, Williams DW, Aiken AH, Hughes RT. Initial Referring Physician and Radiologist Experience with Neck Imaging Reporting and Data System. Laryngoscope. 2021 Jul 17.
    View in: PubMed
    Score: 0.713
  3. Hughes RT, Razavian NB, Smith S, D'Agostino RB, Bunch PM, Ponnatapura J, Royce TJ, Ververs JD, Nightingale CL, Weaver KE, Farris MK. Radiologist Involvement in Radiation Oncology Peer Review: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Dec 02; 7(12):e2452667.
    View in: PubMed
    Score: 0.225
  4. Hughes RT, Gebeyehu RR, Kalada JM, Lycan TW, Frizzell BA, Kinney RD, D'Agostino RB, Bunch PM, Triozzi P, Zhang W, Furdui CM, Porosnicu M. Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer. Future Oncol. 2023 May 18.
    View in: PubMed
    Score: 0.202
  5. Patel Z, Schroeder JA, Bunch PM, Evans JK, Steber CR, Johnson AG, Farris JC, Hughes RT. Discordance Between Oncology Clinician-Perceived and Radiologist-Intended Meaning of the Postradiotherapy Positron Emission Tomography/Computed Tomography Freeform Report for Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2022 Aug 18.
    View in: PubMed
    Score: 0.192
  6. Johansson ED, Hughes RT, Meegalla NT, Porosnicu M, Patwa HS, Lack CM, Bunch PM. Neck Imaging Reporting and Data System Category 3 on Surveillance Computed Tomography: Incidence, Biopsy Rate, and Predictive Performance in Head and Neck Squamous Cell Carcinoma. Laryngoscope. 2022 Jan 19.
    View in: PubMed
    Score: 0.185
  7. Bunch PM, Patwa HS, Hughes RT, Porosnicu M, Waltonen JD. Patient Selection for Transoral Robotic Surgery (TORS) in Oropharyngeal Squamous Cell Carcinoma: What the Surgeon Wants to Know. Top Magn Reson Imaging. 2021 Apr 01; 30(2):117-130.
    View in: PubMed
    Score: 0.175
  8. Bunch PM, Hughes RT, White EP, Sachs JR, Frizzell BA, Lack CM. The Pharyngolaryngeal Venous Plexus: A Potential Pitfall in Surveillance Imaging of the Neck. AJNR Am J Neuroradiol. 2021 May; 42(5):938-944.
    View in: PubMed
    Score: 0.174
  9. Farris MK, Hughes RT, Wood I, Young P, Lunsford J, Razavian NB, Dezarn WA, Ververs JD, Farris JC, Bunch PM, Royce TJ, Munley MT, Black PJ. Electron Field Shaping with a 3D-Printed, Tungsten-Infused Multileaf Collimator: A Practical, Low-Cost, Reusable, and Customizable Alternative to Traditional Cutouts. Pract Radiat Oncol. 2026 Jan 06.
    View in: PubMed
    Score: 0.061
  10. Farris MK, Razavian NB, Hughes RT, Ververs JD, Snavely AC, Leyrer CM, Tye KE, Allen LF, Pacholke HD, Weaver KE, Bunch PM, Chan MD, Clark H, Puthoff G, Farris JC, Steber CR, Wentworth S, Levine BJ, Nightingale CL, Ponnatapura J. Bridging the Communication Gaps: A Prospective Single-Arm Pilot Study Testing the Feasibility of Interdisciplinary Radiotherapy Planning in Locally Advanced Lung Cancer. Acad Radiol. 2023 Feb 07.
    View in: PubMed
    Score: 0.050
  11. Farris JC, Hughes RT, Razavian NB, Pearce JB, Snavely AC, Chan MD, Steber CR, Leyrer CM, Bunch PM, Willey JS, Farris MK. Brain Metastasis Incidence and Patterns of Presentation After Definitive Treatment of Locally Advanced Non-Small Cell Lung Cancer: A Potential Argument for Brain Magnetic Resonance Imaging Surveillance. Adv Radiat Oncol. 2023; 8(3):101058.
    View in: PubMed
    Score: 0.049
  12. Burcher KM, Lantz JW, Gavrila E, Abreu A, Burcher JT, Faucheux AT, Xie A, Jackson C, Song AH, Hughes RT, Lycan T, Bunch PM, Furdui CM, Topaloglu U, D'Agostino RB, Zhang W, Porosnicu M. Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2021 Nov 16; 13(22).
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.